Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
ancillary, AOCL, calendar, chronic, CME, counterparty, crossing, defense, difficulty, driver, entry, FDII, finite, IIa, IIb, installment, intermittent, Israel, lesser, LP, maximum, noncompetitive, overnight, preexisting, reclaim, registry, rolling, showed, stranded
Removed:
accelerate, American, antidilutive, ASU, AV, AvessTM, calculating, cleared, coordination, customarily, demonstrating, directed, discrete, eluting, ESRD, exemption, femoropopliteal, fistulae, flat, frame, IDA, incidence, inclusion, initiate, intraperiod, investigational, Journal, judgement, legacy, live, Medicare, mortality, pause, plasma, popliteal, PREVEIL, progression, pronouncement, prospective, ratio, recommended, redundant, renal, retrospective, scheduled, Simplifying, Subsequently, tangible, timeline, treated, uncompetitive, undertaken, ViaCyte, worth
Filing tables
Filing exhibits
Related press release
Associated SRDX transcripts
SRDX similar filings
Filing view
External links
EXHIBIT 23
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-104258, 333-123521, 333-165098, 333-165101, 333-54266, 333-231199, 333-251486, 333-262922, and 333-271875 on Form S-8 and Registration Statement No. 333-271874 on Form S-3 of our reports dated November 22, 2023, relating to the financial statements and financial statement schedule of Surmodics, Inc. and the effectiveness of Surmodics, Inc.’s internal control over financial reporting appearing in this Annual Report on Form 10-K for the year ended September 30, 2023.
/s/ DELOITTE & TOUCHE LLP
Minneapolis, Minnesota
November 22, 2023